MWNA
SPPI

Marshall Wace North America’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Marshall Wace North America’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-40,214
Closed -$352K – 1993
2018
Q4 		$352K Buy
+40,214
New +$512K ﹤0.01% 856

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace North America's SPPI Position: Q1 2019 in Review

Marshall Wace North America sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 40,214 shares — an estimated $352K sold.

Marshall Wace North America first reported a position in SPPI in Q4 2018 and held it in 1 quarter. The position peaked at $352K in Q4 2018. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

  • Marshall Wace North America reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
  • Marshall Wace North America sold 40,214 Spectrum Pharmaceuticals Inc shares in Q1 2019, an estimated $352K.
  • Marshall Wace North America first reported a position in Spectrum Pharmaceuticals Inc in Q4 2018 and held it in 1 quarter.
  • Marshall Wace North America's Spectrum Pharmaceuticals Inc position peaked at $352K in Q4 2018.
  • 173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.